This review highlights the challenges in managing pregnant women with heritable thrombophilias due to the lack of high-quality data and the risks of anticoagulant-related maternal and fetal complications.
No takes yet. Share an insight, caveat, or question.
Management of pregnant women with heritable thrombophilias requires individualized caution; leaves open the need for high-quality trials to guide therapy.
Shannon M. Bates (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: